drugset / Trial / NCT02501109

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

NCT02501109

Phase 1 Completed 36 enrolled CMG Pharmaceutical Co. Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare the rate and extent of absorption of Aripiprazole Oral Soluble Film 10 mg (Test) versus Abilify® 10 mg tablet (Reference) in healthy male volunteers

Timeline

Start
2015-10
Primary completion
2016-02
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified 10 mg Oral

Indications